20-64076582-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005873.3(RGS19):c.95C>T(p.Ala32Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000471 in 1,612,344 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005873.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RGS19 | ENST00000395042.2 | c.95C>T | p.Ala32Val | missense_variant | 3/6 | 1 | NM_005873.3 | ENSP00000378483.1 | ||
RGS19 | ENST00000332298.9 | c.95C>T | p.Ala32Val | missense_variant | 3/6 | 1 | ENSP00000333194.5 | |||
RGS19 | ENST00000479996.1 | n.197C>T | non_coding_transcript_exon_variant | 2/2 | 2 | |||||
RGS19 | ENST00000493165.1 | n.681C>T | non_coding_transcript_exon_variant | 3/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152246Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000924 AC: 23AN: 248830Hom.: 0 AF XY: 0.000104 AC XY: 14AN XY: 134926
GnomAD4 exome AF: 0.0000397 AC: 58AN: 1459980Hom.: 0 Cov.: 31 AF XY: 0.0000496 AC XY: 36AN XY: 726316
GnomAD4 genome AF: 0.000118 AC: 18AN: 152364Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74510
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 10, 2024 | The c.95C>T (p.A32V) alteration is located in exon 3 (coding exon 2) of the RGS19 gene. This alteration results from a C to T substitution at nucleotide position 95, causing the alanine (A) at amino acid position 32 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at